Skip to content

IGM Biosciences

  • Leadership Team
  • Investors & News
  • Contact Us

Archives: Publications

Publications

Cutting-edge approaches to B-cell depletion in autoimmune diseases

Front. Immunol., 08 October 2024
Sec. Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Volume 15 – 2024 | https://doi.org/10.3389/fimmu.2024.1454747

Multimeric Anti-DR5 IgM Agonist Antibody IGM-8444 Is a Potent Inducer of Cancer Cell Apoptosis and Synergizes with Chemotherapy and BCL-2 Inhibitor ABT-199

Molecular Cancer Therapeutics, October 28, 2021
Mol Cancer Ther (2021) 20 (12): 2483–2494.

Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants

Nature, June 3, 2021

Structure, Function, and Therapeutic Use of IgM Antibodies

Antibodies – Special Issue Structure and Function of Antibodies, October 13, 2020
Antibodies 2020, 9(4), 53

All content © IGM Biosciences, Inc.      Privacy Policy     Cookies Notice   Terms of Use info@igmbio.com
Site Credit

LinkedIn